Skip to Content
Printer-Friendly Version

Meeting Schedule

Date / Time Studies & Bills Location Session  Note
  • Étude d'un projet d'ordre du jour (travaux futurs)
    • Consideration of a draft agenda (future business)
Room 9, Victoria Building 40-2 [Link to the notice of this meeting]
In Camera
When the Senate rises but not before time shown above.
  • Bill S-8, An Act to implement conventions and protocols concluded between Canada and Colombia, Greece and Turkey for the avoidance of double taxation and the prevention of fiscal evasion with respect to taxes on income
    • Parry Athenaios, Expert Advisor, Tax Treaties (Department of Finance Canada)
    • Alain Castonguay, Senior Chief, Tax Treaties (Department of Finance Canada)
    • Gérard Lalonde, Director, Tax Legislation Division (Department of Finance Canada)
    • Tim Wach, Director, Legislative Development and Chief Legislative Counsel (Department of Finance Canada)
  • Étude d'un projet d'ordre du jour (travaux futurs)
    • Consideration of a draft agenda (future business)
Room 9, Victoria Building 40-2 [Link to the notice of this meeting]
Partial In Camera
  • Bill S-232, An Act to amend the Patent Act (drugs for humanitarian purposes)
    • Frederick M. Abbott, Edward Ball Eminent Scholar, Professor of International Law (Florida State University College of Law)
    • Antony Taubman, Director of Intellectual Property Division (World Trade Organization (WTO))
Room 9, Victoria Building 40-2 [Link to the notice of this meeting]
When the Senate rises but not before time shown above.
  • Bill S-232, An Act to amend the Patent Act (drugs for humanitarian purposes)
    • Professor Amir Attaran, Associate Professor in the Faculties of Law and Medicine (University of Ottawa)
    • Glen Shepherd, President and CEO (Health Partners International of Canada)
Room 9, Victoria Building* 40-2 [Link to the notice of this meeting]
  • S-203, Municipal Modernization and Business Development Bank of Canada Act
    • Jack Mintz, Director and Palmer Chair in Public Policy (University of Calgary School of Public Policy)
  • The present state of the domestic and international financial system.
    • Jack Mintz, Director and Palmer Chair in Public Policy (University of Calgary School of Public Policy)
Room 9, Victoria Building* 40-2 [Link to the notice of this meeting]
  • Bill S-232, An Act to amend the Patent Act (drugs for humanitarian purposes)
    • Marilyn Coolen, Atlantic Representative - Leadership Team, National Advocacy Committee (Grandmothers to Grandmothers Campaign)
    • Richard Dearden, Partner (Gowling, Lafleur, Henderson LLP)
    • Ywe Looper, Manager Patents (Boehringer Ingelheim (Canada) Ltd)
    • Paul Lucas, President and CEO (GlaxoSmithKline Canada)
    • Gillian Sandeman, Ontario South-East Representative, Leadership Team, National Advocacy Committee (Grandmothers to Grandmothers Campaign)
    • Kathleen Wallace-Deering, Co-Chair, National Advocacy Committee (Grandmothers to Grandmothers Campaign)
    • Linda Watson, Prairies Rep - Leadership Team, National Advocacy Committee (Grandmothers to Grandmothers Campaign)
    • Russell Williams, President (Canada's Research-Based Pharmaceuticals Companies)
Room 9, Victoria Building* 40-2 [Link to the notice of this meeting]
  • The present state of the domestic and international financial system.
    • David J. Rodgers, Special Advisor to the Director General, Economic Policy Bureau (Foreign Affairs and International Trade Canada)
Room 9, Victoria Building* 40-2 [Link to the notice of this meeting]
When the Senate rises but not before time shown above.
  • The present state of the domestic and international financial system.
    • Mark J. Carney, Governor (Bank of Canada)
    • Paul Jenkins, Senior Deputy Governor (Bank of Canada)
Room 9, Victoria Building* 40-2 [Link to the notice of this meeting]
  • Bill S-232, An Act to amend the Patent Act (drugs for humanitarian purposes)
    • Tenu Avafia, United Nations Development Programme (UNDP), Policy Specialist, Intellectual Property and Trade (Unicef)
    • Bruce Clark, Vice-President, Regulatory and Medical Affairs (Apotex Inc.)
    • Meg French, Director, International Programmes (Unicef)
    • Robert Gass, Pediatric HIV Focal Point based at UNICEF (Unicef)
    • Jack Kay, President and Chief Operating Officer (Apotex Inc.)
    • Jim Keon, President (Canadian Generic Pharmaceutical Association)
Room 9, Victoria Building* 40-2 [Link to the notice of this meeting]
  • Bill S-232, An Act to amend the Patent Act (drugs for humanitarian purposes)
    • Aria Ilyad Ahmad, UAEM Chapter Leader, University of Toronto (Universities Allied for Essential Medicines)
    • Richard Elliott, Executive Director (Canadian HIV/AIDS Legal Network)
    • Rachel Kiddell-Monroe, Advisor, MSF Campaign for Access to Essential Medicines (Doctors Without Borders)
    • Cailin Morrison, Legal Advisor, Trade and Intellectual Property Law (Canadian HIV/AIDS Legal Network)
Room 9, Victoria Building* 40-2 [Link to the notice of this meeting]
* Please note meeting changes.
Legend
Audio Webcast
Audio Webcast
Video Webcast
Video Webcast
Meeting
Meeting
Minutes
Minutes
Transcripts
Transcripts
Interim
Interim
Unrevised information from meeting notice
Unrevised information from meeting notice
Subject to Change
Subject to Change